Skip to search formSkip to main contentSkip to account menu

MVPP protocol

Known as: MVPP, Mechlorethamine/Prednisone/Procarbazine/Vinblastine, NM/PCB/PRED/VBL 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
Eighteen men (mean age 27, range 18‐30 years) treated for Hodgkin's disease with 6‐8 courses of MVPP (Mustine, Vinblastine… 
Review
1987
Review
1987
Twenty four patients with angio-immunoblastic lymphadenopathy (AILD) presenting between 1974 and 1985 have been reviewed… 
1986
1986
One hundred and fourteen patients with clinical or pathological stages IIIB and IV Hodgkin's disease have been treated with MVPP… 
Highly Cited
1984
Highly Cited
1984
This paper reports the five-year follow-up (range, 1-8 years) of 56 patients with pathologic stage IIIA Hodgkin's disease… 
Highly Cited
1982
Highly Cited
1982
The effects of Hodgkin's disease and quadruple chemotherapy on gonadal function have been investigated in 93 male patients with… 
Highly Cited
1980
Highly Cited
1980
The dose of combination chemotherapy in Hodgkin's disease is commonly calculated from a formula based on the body surface area. A… 
Highly Cited
1978
Highly Cited
1978
During January 1968 to December 1972, 133 patients with advanced Hodgkin's disease (HD) were admitted to hospital for combination…